GSK Investments in U.S. Healthcare Industry
British pharmaceutical giant GSK announces $30 billion investment to strengthen presence in American market.
British pharmaceutical giant GSK announces $30 billion investment to strengthen presence in American market.
Promising results from a Phase 2 trial of an over-the-counter nasal spray in reducing COVID infections.
